Morgan Stanley Reduces Earnings Estimate for Goldman Sachs

Aug. 27 (Bloomberg) -- Morgan Stanley cut Goldman Sachs & Co.'s third-quarter earnings estimate to $1.65, down from a previous estimate of $3, saying that Goldman ``is not immune to difficult market conditions.'' Included are analysts' calls for Hewlett-Packard Co., AMR Corp., NRG Energy Inc., Oneok Inc., Rigel Pharmaceuticals Inc., Incyte Corp., McCormick & Co., OAO Wimm-Bill-Dann Foods and Amylin Pharmaceuticals Inc.